Genewindow Research Corp. is a leading innovator in the development of groundbreaking medical technologies. Founded in 2015, the company is driven by a team of world-class scientists, engineers, and clinicians who are dedicated to addressing some of the most pressing challenges in healthcare. With a focus on areas like regenerative medicine, precision diagnostics, and digital therapeutics, Genewindow is committed to translating cutting-edge scientific discoveries into practical solutions that can improve and save lives. Through a unique blend of academic rigour, entrepreneurial spirit, and collaborative partnerships, the company is pioneering transformative products and services that have the potential to redefine the standard of care across a wide range of medical disciplines.

President & Founder

Dr. Mahmood Tazari is a highly respected health science researcher with over 20 years of experience in the field. He has published numerous scientific papers in leading peer-reviewed journals, contributing valuable insights and discoveries to advance the understanding of various health-related topics.
Dr. Tazari earned his Ph.D. in Public Health/Epidemiology, M.Sc. in Mathematics and M.Sc. in Genetics from top-ranked universities, where he specialized in epidemiology and mathematical modelling in health research.
He is passionate about translating scientific findings into practical applications that can improve population health and inform policy decisions. With his wealth of experience in, bridging mathematical algorithms, Artificial Intelligence, and medical research, analytical rigour, and unwavering commitment to public health, Dr. Tazari continues to be a respected voice in the scientific community and a valuable asset in the field of health sciences.